These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 87722)
21. [Pregnancy in health care personnel handling cancer medications]. Hemminki K; Kyyrönen P; Lindbohm ML; Selevan SG Katilolehti; 1986 Jun; 91(4):158-67. PubMed ID: 3640895 [No Abstract] [Full Text] [Related]
22. Bacterial urinary assay in monitoring exposure to mutagens and carcinogens. Vainio H; Sorsa M; Falck K IARC Sci Publ; 1984; (59):247-58. PubMed ID: 6400094 [TBL] [Abstract][Full Text] [Related]
23. Urinary screening for potentially genotoxic exposures in a chemical industry. Ahlborg G; Bergström B; Hogstedt C; Einistö P; Sorsa M Br J Ind Med; 1985 Oct; 42(10):691-9. PubMed ID: 3899158 [TBL] [Abstract][Full Text] [Related]
24. [Nurses' working environment. Elimination of cytostatic agents--focus on protection effort]. Bråthen A; Rønning ME; Spilling J Sykepleien; 1986 Aug; 73(14):19-23, 42. PubMed ID: 3638820 [No Abstract] [Full Text] [Related]
25. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine]. Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511 [TBL] [Abstract][Full Text] [Related]
26. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Sessink PJ; Bos RP Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582 [TBL] [Abstract][Full Text] [Related]
27. Quantification of urinary mutagens in nurses during potential antineoplastic agent exposure. A pilot study with concurrent environmental and dietary control. Caudell KA; Vredevoe DL; Dietrich MF; Caudell TP; Hoban MJ; Block JB Cancer Nurs; 1988 Feb; 11(1):41-50. PubMed ID: 3359427 [No Abstract] [Full Text] [Related]
28. Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Nikula E; Kiviniitty K; Leisti J; Taskinen PJ Scand J Work Environ Health; 1984 Apr; 10(2):71-4. PubMed ID: 6382593 [TBL] [Abstract][Full Text] [Related]
29. [The correlation between the excretion of thioethers and their mutagenic activity in urine in workers of different occupational groups]. Kouros BM; Böttger A; Dehnen W Zentralbl Hyg Umweltmed; 1989 Nov; 189(2):125-34. PubMed ID: 2604844 [TBL] [Abstract][Full Text] [Related]
30. Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide. Evelo CT; Bos RP; Peters JG; Henderson PT Int Arch Occup Environ Health; 1986; 58(2):151-5. PubMed ID: 3744569 [TBL] [Abstract][Full Text] [Related]
31. Immune function in nurses handling cytostatic drugs. Lassila O; Toivanen A; Nordman E Lancet; 1980 Aug; 2(8192):482. PubMed ID: 6106128 [No Abstract] [Full Text] [Related]
32. Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests. Labuhn K; Valanis B; Schoeny R; Loveday K; Vollmer WM Cancer Nurs; 1998 Apr; 21(2):79-89. PubMed ID: 9556934 [TBL] [Abstract][Full Text] [Related]
35. Excretion of mutagens in sweat from humans treated with anti-neoplastic drugs. Madsen ES; Larsen H Cancer Lett; 1988 Jun; 40(2):199-202. PubMed ID: 3383178 [TBL] [Abstract][Full Text] [Related]
36. Detection of occupational and environmental exposures by bacterial mutagenesis assays of human body fluids. Everson RB J Occup Med; 1986 Aug; 28(8):647-55. PubMed ID: 3746486 [TBL] [Abstract][Full Text] [Related]
37. Antineoplastic drugs and spontaneous abortion in nurses. N Engl J Med; 1986 Apr; 314(16):1048-51. PubMed ID: 3960073 [No Abstract] [Full Text] [Related]
38. [Mutagenic substances in the urine of nurses in an oncological department]. Rørth M; Jørgensen J; Jørgensen V; Knudsen I; Larsen JC; Munck F Ugeskr Laeger; 1983 Feb; 145(7):475-8. PubMed ID: 6845511 [No Abstract] [Full Text] [Related]
39. [Potential genotoxic effects of cytostatics in occupationally-exposed persons]. Brumen V; Horvat D Arh Hig Rada Toksikol; 1992 Dec; 43(4):313-9. PubMed ID: 1297307 [TBL] [Abstract][Full Text] [Related]
40. A comparison of mutation spectra detected by the Escherichia coli lac(+) reversion assay and the Salmonella typhimurium his(+) reversion assay. Ohta T; Watanabe-Akanuma M; Yamagata H Mutagenesis; 2000 Jul; 15(4):317-23. PubMed ID: 10887210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]